It’s seldom that drug companies have the opportunity to develop a product that’s relevant to the entire world. In fact, it takes a global pandemic. IQVIA Institute for Human Data Science took on the task of estimating the financial impact of protecting the population from COVID-19, and the numbers are staggering. According to a recent FiercePharma article that discussed the figures, global vaccine sales will reach $157B by 2025. This estimate accounts for dramatic drops in the cost per dose going from an average of $22 per shot in 2021 to $9 per shot in 2023.
COVID-19 Vaccine Sales Projections are Impressive
Pharmaceutical companies that invested in coronavirus vaccine development will see big revenues.
May 4, 2021
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
